The Quinone-Derived Small Molecule M5N32 Is an Effective Anti-Helicobacter pylori Agent Both In Vivo and In Vitro.

Liyuan WangYanbo YuYucen TaoMingzhong ZhaoLu ZhangJunyuan XueYican ZhaoPeng ZhanYundong Sun

Published in: The Journal of infectious diseases (2022)

M5N32 is effective in the treatment of H. pylori infections, providing potential development of anti-H. pylori medicines in the treatment of H. pylori infections.

Keyphrases

helicobacter pylori
small molecule
helicobacter pylori infection
combination therapy
risk assessment
climate change
replacement therapy